Bepotastine - redOrbit

News - Bepotastine

ISTA Pharmaceuticals Achieves 2010 Revenue and Earnings Guidance; Provides 2011 Financial Guidance and Updates Key Plans

2011-01-05 15:30:00

IRVINE, Calif., Jan. 5, 2011 /PRNewswire/ -- ISTA Pharmaceuticals, Inc.

ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis

2010-12-14 06:30:00

IRVINE, Calif., Dec. 14, 2010 /PRNewswire/ -- ISTA Pharmaceuticals, Inc.

ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results

2010-11-02 15:00:00

IRVINE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the quarter ended September 30, 2010. Third quarter 2010 net revenues were $42.0 million, an increase of 31% from the third quarter of 2009.

ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis

2010-10-06 06:30:00

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc.

ISTA Pharmaceuticals Reports Second Quarter 2010 Financial Results

2010-08-04 15:00:00

IRVINE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) ("ISTA"), today reported financial results for the quarter ended June 30, 2010. Second quarter 2010 net revenues were $35.1 million, an increase of 46% from the second quarter of 2009.

More News (23 articles) »

News - Bepotastine

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health